top of page
Novartis Logo.png

The video window is being blocked by your browser.

Please try accessing from an alternative browser or device

2023_09_21 Menti.png

Join the conversation...

Please type your questions below during the broadcast... Click 'Open Q&A'

Alternatively scan the above QR code with your device's camera

Please note that all questions submitted will be moderated by Novartis to align with compliance and industry standards.

Header Text V2.png
Kisqali Logo.png

This meeting is organised and funded by Novartis Pharmaceuticals UK Ltd and is classed as promotional under the Association of the British Pharmaceutical Industry (ABPI) Code. It is intended for GB healthcare professionals only.

Company products will be discussed at this meeting and Great Britain prescribing information is available above.

UK | September 2023 | 294952

Your attendance at the event is governed by our Healthcare Professional Event Attendance Terms. By attending the event, you are agreeing to be bound by such terms.

Adverse events should be reported. Reporting forms and information can be found at (UK).

Adverse events should also be reported to Novartis via or online through the pharmacovigilance intake (PVI) tool at

If you have a question about a product, please contact Medical Information on 01276 698370 or by email at

bottom of page